| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $4.8M | -6.7% |
| SG&A Expense | $3.5M | +46.1% |
| Operating Income | -$8.3M | -10.2% |
| Interest Expense | $305K | +272.0% |
| Income Tax | $0 | — |
| Net Income | -$10.5M | -39.0% |
| EPS (Basic) | -$1.38 | +37.8% |
| EPS (Diluted) | -$1.38 | +37.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $8.6M | +552.2% |
| Current Assets | $15.5M | +966.2% |
| Total Assets | $17.3M | +884.3% |
| Current Liabilities | $4.0M | -41.9% |
| Total Liabilities | $4.1M | -39.7% |
| Stockholders' Equity | $13.2M | +187.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.2M | -31.6% |
| Investing Cash Flow | -$6.0M | — |
| Financing Cash Flow | $20.5M | +809.9% |